Finance

Lists
300406:SHE
Beijing Strong Biotechnologies Inc
CNÂ¥11.73
-0.34%
(-0.040) 1D
Aug 28, 3:04:16 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300406...
Open
CNÂ¥11.73
High
CNÂ¥11.78
Low
CNÂ¥11.65
Mkt. cap
6.88B
Avg. vol.
5.40M
Volume
3.81M
Dividend
10.23%
Quarterly dividend
CNÂ¥0.30
Ex-dividend date
May 29, 2026
P/E ratio
31.25
52-wk high
CNÂ¥16.05
52-wk low
CNÂ¥10.52
EPS
CNÂ¥0.38
Shares outstanding
586.14M
No. of employees
998
Open
CNÂ¥11.73
High
CNÂ¥11.78
Low
CNÂ¥11.65
Mkt. cap
6.88B
Avg. vol.
5.40M
Volume
3.81M
Dividend
10.23%
Quarterly dividend
CNÂ¥0.30
Ex-dividend date
May 29, 2026
P/E ratio
31.25
52-wk high
CNÂ¥16.05
52-wk low
CNÂ¥10.52
EPS
CNÂ¥0.38
Shares outstanding
586.14M
No. of employees
998
About Beijing Strong Biotechnologies Inc
CEO-
Employees998
FoundedMar 29, 2001
Headquarters-
SectorBiotechnology
Websitebsbe.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
343.38M
343.79M
334.81M
343.87M
Cost of goods sold
67.34M
80.75M
60.47M
69.40M
Cost of revenue
67.34M
80.75M
60.47M
69.40M
Research and development expenses
43.47M
53.93M
40.55M
42.42M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
105.98M
91.37M
100.28M
87.28M
Operating expense
137.43M
163.25M
146.16M
128.77M
Total operating expenses
204.77M
244.00M
206.63M
198.17M
Operating income
138.60M
99.80M
128.18M
145.70M
Other non operating income
-18.25M
615.35K
313.37K
-40.63M
EBT including unusual items
110.58M
-70.71M
123.98M
116.56M
EBT excluding unusual items
110.27M
102.06M
120.91M
119.98M
Income tax expense
13.22M
11.82M
18.37M
11.83M
Effective tax rate
11.96%
-16.72%
14.82%
10.15%
Other operating expenses
5.27M
3.38M
5.33M
-922.59K
Net income
97.23M
-82.59M
105.61M
104.70M
Net profit margin
28.31%
-24.02%
31.54%
30.45%
Earnings per share
-
-
-
-
Interest and investment income
1.51M
16.35M
4.86M
14.91M
Interest expense
-12.37M
-13.25M
-12.44M
-
Net interest expenses
-10.87M
3.10M
-7.58M
14.91M
Depreciation and amortization charges
-
-
-
-
EBITDA
155.77M
116.77M
145.15M
163.41M
Gain or loss from assets sale
-749.60K
2.87M
-
350.14K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps